Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Chames

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|June 13, 2013
Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cellsCaroline Rozan, Amélie Cornillon, Corinne Pétiard, et al.
Nucleic Acids Research|November 30, 2006
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequencesJulianne Smith, Sylvestre Grizot, Sylvain Arnould, et al.
Journal of Virology|February 21, 2012
Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functionsJérôme Bouchet, Cécile Hérate, Carolin A Guenzel, et al.
The Journal of Biological Chemistry|November 13, 2004
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3Martin Hülsmeyer, Patrick Chames, Roman C Hillig, et al.
Oncoimmunology|April 16, 2024
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responsesAntonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona, et al.
Nature Communications|January 7, 2026
Protection against lethal canine distemper virus infection by a dual epitope-targeting synthetic antibodyMelanie Scherer, Nadia Djabeur, Oliver Siering, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobesAlyona Sukhanova, Klervi Even-Desrumeaux, Aymric Kisserli, et al.
Journal of Translational Medicine|February 16, 2024
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerizationNicolas De Leiris, Pascale Perret, Charlotte Lombardi, et al.
Med (New York, N.Y.)|February 11, 2023
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancerAshley L Kiemen, Alexander Ioannis Damanakis, Alicia M Braxton, et al.
Scientific Reports|March 17, 2018
Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dotsFernanda Ramos-Gomes, Julia Bode, Alyona Sukhanova, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|June 13, 2013
Single-domain antibody-based and linker-free bispecific antibodies targeting FcγRIII induce potent antitumor activity without recruiting regulatory T cellsCaroline Rozan, Amélie Cornillon, Corinne Pétiard, et al.
Nucleic Acids Research|November 30, 2006
A combinatorial approach to create artificial homing endonucleases cleaving chosen sequencesJulianne Smith, Sylvestre Grizot, Sylvain Arnould, et al.
Journal of Virology|February 21, 2012
Single-domain antibody-SH3 fusions for efficient neutralization of HIV-1 Nef functionsJérôme Bouchet, Cécile Hérate, Carolin A Guenzel, et al.
The Journal of Biological Chemistry|November 13, 2004
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3Martin Hülsmeyer, Patrick Chames, Roman C Hillig, et al.
Oncoimmunology|April 16, 2024
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responsesAntonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona, et al.
Nature Communications|January 7, 2026
Protection against lethal canine distemper virus infection by a dual epitope-targeting synthetic antibodyMelanie Scherer, Nadia Djabeur, Oliver Siering, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 16, 2011
Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobesAlyona Sukhanova, Klervi Even-Desrumeaux, Aymric Kisserli, et al.
Journal of Translational Medicine|February 16, 2024
A single-domain antibody for the detection of pathological Tau protein in the early stages of oligomerizationNicolas De Leiris, Pascale Perret, Charlotte Lombardi, et al.
Med (New York, N.Y.)|February 11, 2023
Tissue clearing and 3D reconstruction of digitized, serially sectioned slides provide novel insights into pancreatic cancerAshley L Kiemen, Alexander Ioannis Damanakis, Alicia M Braxton, et al.
Scientific Reports|March 17, 2018
Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dotsFernanda Ramos-Gomes, Julia Bode, Alyona Sukhanova, et al.
Pageof 9